Skin Neoplasms  >>  cyclosporine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00129961: Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Completed
4
86
US, Canada, RoW
sirolimus, cyclosporine or tacrolimus
Wyeth is now a wholly owned subsidiary of Pfizer
Skin Neoplasms, Kidney Transplantation
01/09
01/09

Download Options